| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/03/1985 | EP0136153A2 Modified sheet of material and method of making and using same in connection with biochemical procedures |
| 04/03/1985 | EP0135951A2 Method for production of an anti-mastitis polyvalent vaccine |
| 04/03/1985 | EP0135841A2 Herpes simplex virus subunit vaccine |
| 04/03/1985 | EP0135788A1 Muramyldipeptide active ester derivatives |
| 04/03/1985 | EP0135712A2 Antigens and monoclonal antibodies reactive against sporozoites of eimeria spp. |
| 04/02/1985 | US4508831 Anti-streptolysin O latex reagent and process for the preparation thereof |
| 04/02/1985 | US4508708 Picorna virus antigens, stabilizer |
| 04/02/1985 | US4508643 Human chorionic govadotropin; low cross-reactivity |
| 04/02/1985 | CA1184862A1 Filtration method for cell produced antiviral substances |
| 04/02/1985 | CA1184846A1 Non-a, non-b hepatitis-associated antigen and diagnostic reagent |
| 03/28/1985 | WO1985001353A1 A method of determining changes occurring in cartilage |
| 03/27/1985 | EP0135435A2 Immunogenic HBsAg derived from transformed yeast |
| 03/27/1985 | EP0135378A1 Reagent for quantitative determination of microorganisms |
| 03/27/1985 | EP0135376A2 Polyoxypropylene-polyoxyethylene block polymer based adjuvants and vaccines using them |
| 03/27/1985 | EP0135352A2 Reagent for use in detecting antibody to human T-cell leukaemia virus antigen |
| 03/27/1985 | EP0135277A1 Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mRNAs, receptors, methods and diagnostics using the same |
| 03/27/1985 | EP0135129A2 Reagent for immunological determination |
| 03/27/1985 | EP0135073A2 Antigens and monoclonal antibodies reactive against merozites of eimeria spp. |
| 03/27/1985 | EP0135071A2 Luminescence immuno assay for haptenes and a chemiluminescent labeled haptene conjugate to be used in the assay, and a method for its preparation |
| 03/27/1985 | EP0135051A1 Immunoassay for the determination of antibodies against native DNA |
| 03/27/1985 | EP0135022A2 Allergen-containing composition |
| 03/27/1985 | EP0134803A1 Monoclonal antibody |
| 03/26/1985 | US4507234 Conjugate having cytotoxicity and process for the preparation thereof |
| 03/26/1985 | CA1184490A1 Snake venoms for treatment of neurological and related disorders |
| 03/20/1985 | EP0134703A1 Immunogenic composition comprising live encysted protozoa |
| 03/20/1985 | EP0134631A1 Peptides, pharmaceutical compositions, genes, vectors, host organisms, processes for their production and diagnostic reagents |
| 03/20/1985 | EP0134552A2 Monoclonal antibody with a high affinity for digoxin |
| 03/20/1985 | EP0134307A2 Preactivated surfaces of synthetic materials for immobilizing organochemical and biological substances, process for preparing them and their use |
| 03/19/1985 | US4506017 Modified Pasteurella haemolytica bacteria |
| 03/19/1985 | US4506016 Hepatitis-A viruses adapted to human fibroblast cells |
| 03/19/1985 | US4505892 Infectious bronchitis vaccine for poultry |
| 03/19/1985 | CA1184116A2 Infectious bronchitis vaccines for poultry and process for the preparation of such vaccines |
| 03/19/1985 | CA1184115A1 Infectious bronchitis vaccines for poultry and process for the preparation of such vaccines |
| 03/14/1985 | WO1985000977A1 Vaccine and antigen against paludism and preparation process thereof |
| 03/14/1985 | WO1985000976A1 Method and materials for development of immunological responses protective against malarial infection |
| 03/14/1985 | WO1985000975A1 Method and materials for development of immunological responses protective against malarial infection |
| 03/14/1985 | WO1985000974A1 Antibody compositions of therapeutic agents having an extended serum half-life |
| 03/12/1985 | US4504587 Complexing labeled mixture with antibodies and quantifying antigen-antibody complex |
| 03/06/1985 | EP0133833A1 Compositions of vaccines conditioned for the vaccination of immunitarily non-naive subjects against a predetermined pathogenic agent and containing a haptene itself comprising an antigenic site characteristic of said pathogenic agent or an oligomer of this haptene |
| 03/05/1985 | US4503036 Process for producing a biochemical vaccine against Salmonella infection |
| 03/05/1985 | CA1183527A1 Antigenic peptide compound |
| 03/05/1985 | CA1183477A1 Method for the preparation of glucosyltransferase |
| 03/05/1985 | CA1183473A2 Infectious bronchitis vaccines for poultry and process for the preparation of such vaccines |
| 03/05/1985 | CA1183472A2 Veterinary vaccines |
| 03/05/1985 | CA1183470A1 Hybrid cell line for producing monoclonal antibody to a human prothymocyte antigen, antibody, and methods |
| 03/05/1985 | CA1183469A1 Hybrid cell line for producing complement-fixing monoclonal antibody to human suppressor t cells, antibody, and method |
| 03/05/1985 | CA1183453A1 Composition of a novel immunogen for protection against diarrheal disease caused by enterotoxigenic escherichia coli |
| 03/05/1985 | CA1183452A1 Rabies vaccine |
| 03/05/1985 | CA1183451A1 Method for producing a csap tryptic peptide and anti- csap antibodies |
| 02/28/1985 | WO1985000832A1 Production of streptococal m protein immunogens and molecular probes |
| 02/28/1985 | WO1985000807A1 Polypeptide-induced monoclonal antibodies to oncoproteins |
| 02/28/1985 | WO1985000752A1 Immunogenic composition comprising live encysted protozoa |
| 02/28/1985 | WO1985000749A1 Improvements in or relating to immunological compositions |
| 02/27/1985 | EP0133599A2 Vaccines and compositions against hepatitis B viral infections |
| 02/27/1985 | EP0133553A2 Reagent and process for the quantitative determination of antibodies |
| 02/27/1985 | EP0133551A2 Monoclonal antibody which recognizes a structure which is common to the human interleukin-2 (TCGF) and to the light chain lambda of human immunoglobulin, and hybridoma cell lines producing this monoclonal antibody |
| 02/27/1985 | EP0133540A1 Receptor assays using labeled monoclonal anti-idiotypic antibodies |
| 02/26/1985 | US4501736 Genus epimedium-bactericides |
| 02/26/1985 | CA1183129A1 Lipophilic muramyl peptides and processes for their manufacture |
| 02/26/1985 | CA1183128A1 Muramyldipeptide derivatives |
| 02/26/1985 | CA1183084A1 Intravenously injectable immune serum globulin |
| 02/26/1985 | CA1183083A1 Herpes virus vaccine |
| 02/20/1985 | EP0133200A1 Diagnostic antigen for swine pseudorabies disease virus carriers |
| 02/19/1985 | US4500639 Culturing Bordetella in media containing etherified cyclodextrin |
| 02/19/1985 | US4500638 Poultry vaccine |
| 02/19/1985 | US4500513 Influenza vaccine production in liquid cell culture |
| 02/19/1985 | US4500512 Phosphate buffer containing calcium and magnesium ions, lactose, sorbitol, and an amino acid |
| 02/19/1985 | US4500451 New protein PP13 extracted from human placental tissues and use thereof |
| 02/19/1985 | CA1182811A1 Thiolated polypeptide compound derived from a tetanus toxin fragment, the process for its obtention and its applications |
| 02/19/1985 | CA1182749A1 Non-allergenic protective antigens from molds |
| 02/14/1985 | WO1985000522A1 Method for enhancing target specificity of antibody localization and clearance of non-target diagnostic and therapeutic principles |
| 02/13/1985 | EP0133123A1 Immunogens of papilloma viruses |
| 02/13/1985 | EP0133063A1 Immunologically reactive non-glycosylated amino acid chains of glycoprotein B of herpes virus types 1 and 2 |
| 02/13/1985 | EP0132488A2 Rat antibody to human chorionic gonadotropin |
| 02/12/1985 | USRE31830 Infectious bronchitis vaccine for poultry |
| 02/12/1985 | US4499186 Hydrolysis of substrate |
| 02/12/1985 | US4499080 Synthetic ST toxin, process for its preparation and its use as a vaccinating agent |
| 02/12/1985 | US4499073 Intravenously injectable immune serum globulin |
| 02/12/1985 | US4499065 Deactivation by blocking thio groups with an iodo- or bromoacetic acid or derivative; desensitization |
| 02/12/1985 | US4499014 Method for purifying gamma-interferon |
| 02/12/1985 | CA1182406A1 Hybrid cell line for producing complement-fixing monoclonal antibody to human t cells, antibody, and methods |
| 01/30/1985 | EP0132281A2 Method of isolating membrane antigens from cells |
| 01/29/1985 | US4496654 Bonded to biotinylated antibody |
| 01/29/1985 | US4496538 Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine |
| 01/29/1985 | CA1181742A1 Antigenic linear peptide compound |
| 01/29/1985 | CA1181702A1 Hybrid cell line for producing monoclonal antibody to a human thymocyte antigen, antibody, and methods |
| 01/29/1985 | CA1181691A1 Vaccinal complex containing a specific antigen and vaccine containing it |
| 01/29/1985 | CA1181685A1 Method for the identification and purification of human lung tumor-associated antigens (hltaa) and clinical detection and determination of these antigens |
| 01/23/1985 | EP0132178A1 Process for the preparation of the principal proteins of hemolysed blood in a non denatured form |
| 01/23/1985 | EP0132021A1 TGF polypeptides, antigenic oligopeptides derived therefrom and antibodies produced therefrom |
| 01/23/1985 | EP0131974A1 Determination of delta-antigens in body fluids |
| 01/23/1985 | EP0131878A2 Process for producing human monoclonal antibodies |
| 01/23/1985 | EP0131864A2 Denaturation-resistant aqueous solutions of proteins, process for preparing them and their use |
| 01/23/1985 | EP0131834A2 Monoclonal antibody having specificity to only one type of an isozyme of human cardiac myosin heavy chain |
| 01/23/1985 | EP0131740A2 Undenatured virus-free biologically active protein derivatives |
| 01/22/1985 | US4495278 Inactivation of virus by heating in dry state |
| 01/22/1985 | US4495096 Process for producing and obtaining anaphylatoxin-and cocytotaxin-containing leucotaxine preparations and of anaphylatoxin and cocytotaxin proteins in molecularly homogeneous, biologically active form |
| 01/22/1985 | CA1181344A1 Immunogenic polysaccharide-protein conjugates |
| 01/17/1985 | WO1985000226A1 Free ligand assay |
| 01/17/1985 | WO1985000184A1 Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors |